Surgery Partners Inc.

NASDAQ: SGRY · Real-Time Price · USD
22.18
-0.50 (-2.20%)
At close: May 09, 2025, 3:59 PM
22.15
-0.11%
After-hours: May 09, 2025, 05:08 PM EDT

Surgery Partners Statistics

Share Statistics

Surgery Partners has 128.19M shares outstanding. The number of shares has increased by 0.41% in one year.

Shares Outstanding 128.19M
Shares Change (YoY) 0.41%
Shares Change (QoQ) 0.39%
Owned by Institutions (%) 99.99%
Shares Floating n/a
Failed to Deliver (FTD) Shares 32,908
FTD / Avg. Volume 3.19%

Short Selling Information

The latest short interest is 9.51M, so 7.48% of the outstanding shares have been sold short.

Short Interest 9.51M
Short % of Shares Out 7.48%
Short % of Float 16.48%
Short Ratio (days to cover) 7.81

Valuation Ratios

The PE ratio is -15.88 and the forward PE ratio is 16.91. Surgery Partners's PEG ratio is -0.01.

PE Ratio -15.88
Forward PE 16.91
PS Ratio 0.86
Forward PS 0.6
PB Ratio 1.49
P/FCF Ratio 12.73
PEG Ratio -0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Surgery Partners.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 2.07.

Current Ratio 1.79
Quick Ratio 1.65
Debt / Equity 2.07
Debt / EBITDA 6.62
Debt / FCF 17.66
Interest Coverage 1.73

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $207,620
Profits Per Employee $-11,206.67
Employee Count 15,000
Asset Turnover 0.39
Inventory Turnover 26.8

Taxes

Income Tax 134.6M
Effective Tax Rate 91.5%

Stock Price Statistics

The stock price has increased by -16.35% in the last 52 weeks. The beta is 1.97, so Surgery Partners's price volatility has been higher than the market average.

Beta 1.97
52-Week Price Change -16.35%
50-Day Moving Average 22.83
200-Day Moving Average 25.96
Relative Strength Index (RSI) 52.99
Average Volume (20 Days) 1,030,098

Income Statement

In the last 12 months, Surgery Partners had revenue of 3.11B and earned -168.1M in profits. Earnings per share was -1.33.

Revenue 3.11B
Gross Profit 745.6M
Operating Income 348.8M
Net Income -168.1M
EBITDA 559.3M
EBIT 348.8M
Earnings Per Share (EPS) -1.33
Full Income Statement

Balance Sheet

The company has 269.5M in cash and 3.7B in debt, giving a net cash position of -3.43B.

Cash & Cash Equivalents 269.5M
Total Debt 3.7B
Net Cash -3.43B
Retained Earnings -737.3M
Total Assets 7.89B
Working Capital 495M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 300.1M and capital expenditures -90.4M, giving a free cash flow of 209.7M.

Operating Cash Flow 300.1M
Capital Expenditures -90.4M
Free Cash Flow 209.7M
FCF Per Share 1.66
Full Cash Flow Statement

Margins

Gross margin is 23.94%, with operating and profit margins of 11.2% and -5.4%.

Gross Margin 23.94%
Operating Margin 11.2%
Pretax Margin 4.72%
Profit Margin -5.4%
EBITDA Margin 17.96%
EBIT Margin 11.2%
FCF Margin 6.73%

Dividends & Yields

SGRY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SGRY is $35, which is 54.5% higher than the current price. The consensus rating is "Buy".

Price Target $35
Price Target Difference 54.5%
Analyst Consensus Buy
Analyst Count 8
Stock Forecasts

Scores

Altman Z-Score 1.04
Piotroski F-Score 5